| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-11 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-10 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |